Articles

  • Jul 18, 2024 | msn.com | Claire Hendershot

    Continue reading More for You

  • Jul 18, 2024 | phys.org | Claire Hendershot

    Developing a new drug can take years of research and cost millions of dollars. Still, more than 90% of drug candidates fail in clinical trials, with even more that never make it to the clinical stage. Many drugs fail because they simply aren't safe.

  • Jul 17, 2024 | broadinstitute.org | Claire Hendershot

    Skip to main content About usThis is Broad Learn about our mission, our values, our history, and partner institutions. People Meet our members, staff scientists, fellows, leadership, and other Broadies. Join Broad Find out how to join the Broad as an employee or associate member. Contact us Find our contact information, directions to our buildings, and directory. Broad@20 Broad turns 20 this year! See how we’re celebrating our 20th anniversary.

  • Jun 11, 2024 | broadinstitute.org | Claire Hendershot

    When Moe Haines first moved from Beirut, Lebanon to the United States for college, his goal was to earn a degree in pharmacy. Haines was the first person in his family to pursue science, and most people he knew with similar interests had chosen a career in medicine. But his first few biology classes in community college exposed him to the possibility of a career in genetics, chemistry, or physics.

  • Mar 20, 2024 | medicalxpress.com | Claire Hendershot

    Researchers have developed statistical tools called polygenic risk scores (PRSs) that can estimate individuals' risk for certain diseases with strong genetic components, such as heart disease or diabetes. However, the data on which PRSs are built is often limited in diversity and scope. As a result, PRSs are less accurate when applied to populations that differ demographically from the PRS training data.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →